Qualitative evaluation of adherence therapy in Parkinson's disease: a multidirectional model

被引:9
作者
Daley, David James [1 ,2 ]
Deane, Katherine Helen O'Leary [3 ]
Gray, Richard John [4 ]
Hill, Rebekah [3 ]
Myint, Phyo Kyaw [5 ]
机构
[1] Univ E Anglia, Norwich Med Sch, Fac Med & Hlth Sci, Norwich NR4 7TJ, Norfolk, England
[2] Norfolk & Norwich Univ Hosp NHSNHS Fdn Trust, Norwich, Norfolk, England
[3] Univ E Anglia, Sch Hlth Sci, Norwich NR4 7TJ, Norfolk, England
[4] Hamad Med Corp, Doha, Qatar
[5] Univ Aberdeen, Sch Med & Dent, Inst Appl Hlth Sci, Epidemiol Grp,Coll Life Sci & Med, Aberdeen, Scotland
关键词
Parkinson's disease; medication; adherence therapy; acceptability; mechanisms; RANDOMIZED CONTROLLED-TRIAL; MEDICATION ADHERENCE; COGNITIVE FUNCTION; CLINICAL-OUTCOMES; PEOPLE; SCHIZOPHRENIA; HUNTINGTONS; LEVODOPA; PROGRAM;
D O I
10.2147/PPA.S80158
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Medication can control the symptoms of Parkinson's disease (PD). Despite this, non-adherence with medication is prevalent in PD. Treatments for improving adherence with medication have been investigated in many chronic conditions, including PD. However, few researchers have evaluated their interventions qualitatively. We investigated the acceptability and potential mechanism of action of adherence therapy (AT) in PD patients and their spouse/ carers who received the intervention as part of a randomized controlled trial. Methods: Sixteen participants (ten patients and six spouses/carers) who had recently completed the trial were purposely selected in order to cover a range of ages and disease severity. Semi-structured interviews were conducted in the participants' homes. Data were transcribed and analyzed using a thematic approach. A second researcher, naive to PD and AT, analyzed the data independently to limit bias. Results: The trial showed that AT significantly improved both medication adherence and quality of life in people with PD. Specifically, patients who received AT reported improvements in mobility, activities of daily living, emotional wellbeing, cognition, communication, and body discomfort. General beliefs about medication also significantly improved in those who received AT compared with controls. In the current qualitative evaluation, a total of 175 codes were generated, which formed eleven subthemes. These could be grouped under three overarching themes, ie, perceptions prior to AT, positive effects of AT, and attributes of AT. Conclusion: This randomized controlled trial is the first to investigate AT in PD. The acceptability and underlying mechanism of the intervention suggest a new multidirectional model of AT in PD which future research should seek to confirm. The findings provide a deeper understanding of AT and will allow clinicians to modify the delivery of the intervention by acknowledging various pathways to improved outcomes.
引用
收藏
页码:989 / 998
页数:10
相关论文
共 29 条
[1]   Caregiver education in Parkinson's disease: formative evaluation of a standardized program in seven European countries [J].
A'Campo, L. E. I. ;
Spliethoff-Kamminga, N. G. A. ;
Macht, M. ;
Roos, R. A. C. .
QUALITY OF LIFE RESEARCH, 2010, 19 (01) :55-64
[2]   Adherence therapy for medication non-compliant patients with hypertension: a randomised controlled trial [J].
Alhalaiqa, F. ;
Deane, K. H. O. ;
Nawafleh, A. H. ;
Clark, A. ;
Gray, R. .
JOURNAL OF HUMAN HYPERTENSION, 2012, 26 (02) :117-126
[3]   The relationship between self-efficacy and self-reported physical functioning in chronic obstructive pulmonary disease and chronic heart failure [J].
Arnold, R ;
Ranchor, AV ;
DeJongste, MJL ;
Köeter, GH ;
Ten Hacken, NHT ;
Aalbers, R ;
Sanderman, R .
BEHAVIORAL MEDICINE, 2005, 31 (03) :107-115
[4]   The expert patient: Valid recognition or false hope? [J].
Badcott D. .
Medicine, Health Care and Philosophy, 2005, 8 (2) :173-178
[5]   One size fits all? What counts as quality practice in (reflexive) thematic analysis? [J].
Braun, Virginia ;
Clarke, Victoria .
QUALITATIVE RESEARCH IN PSYCHOLOGY, 2021, 18 (03) :328-352
[6]   Adherence therapy improves medication adherence and quality of life in people with Parkinson's disease: a randomised controlled trial [J].
Daley, D. J. ;
Deane, K. H. O. ;
Gray, R. J. ;
Clark, A. B. ;
Pfeil, M. ;
Sabanathan, K. ;
Worth, P. F. ;
Myint, P. K. .
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2014, 68 (08) :963-971
[7]   The use of carer assisted adherence therapy for people with Parkinson's disease and their carers (CAAT-PARK): study protocol for a randomised controlled trial [J].
Daley, David J. ;
Deane, Katherine H. O. ;
Gray, Richard J. ;
Worth, Paul F. ;
Clark, Allan B. ;
Sabanathan, Kanagasabesan ;
Pfeil, Michael ;
Myint, Phyo K. .
TRIALS, 2011, 12
[8]   Systematic review on factors associated with medication non-adherence in Parkinson's disease [J].
Daley, David James ;
Myint, Phyo Kyaw ;
Gray, Richard John ;
Deane, Katherine Helen O'Leary .
PARKINSONISM & RELATED DISORDERS, 2012, 18 (10) :1053-1061
[9]   Priority setting partnership to identify the top 10 research priorities for the management of Parkinson's disease [J].
Deane, Katherine H. O. ;
Flaherty, Helen ;
Daley, David J. ;
Pascoe, Roland ;
Penhale, Bridget ;
Clarke, Carl E. ;
Sackley, Catherine ;
Storey, Stacey .
BMJ OPEN, 2014, 4 (12)
[10]   Depression is a risk factor for noncompliance with medical treatment -: Meta-analysis of the effects of anxiety and depression on patient adherence [J].
DiMatteo, MR ;
Lepper, HS ;
Croghan, TW .
ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (14) :2101-2107